Principal Investigator, Site Director
Prior to joining Velocity, Dr. Ludwig-Sengpiel served as the Managing Director of KLB Gesundheltsforschung Lübeck GmbH and has worked as an investigator for nearly 25 years. She has strong expertise in pulmonary indications, including asthma, COPD, sarcoidosis and idiopathic pulmonary fibrosis (IPF). To date, Dr. Ludwig Sengpiel has personally conducted over 90 clinical trials.
